Meeder Asset Management Inc Csl LTD Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$90.51 - $207.38 $1,629 - $3,732	-18 Reduced 5.71%	297 $27,000
Q1 2022 May 10, 2022	BUY	$85.56 - $107.12 $26,951 - $33,742	315 New	315 $31,000
Q4 2021 Feb 11, 2022	SELL	$97.41 - $116.74 $23,670 - $28,367	-243 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$100.62 - $116.66 $804 - $933	-8 Reduced 3.19%	243 $26,000
Q3 2020 Nov 02, 2020	BUY	$95.79 - $111.95 $4,310 - $5,037	45 Added 21.84%	251 $26,000
Q2 2020 Aug 11, 2020	BUY	$90.75 - $104.91 $5,082 - $5,874	56 Added 37.33%	206 $21,000
Q2 2019 Aug 05, 2019	BUY	$68.24 - $75.87 $10,236 - $11,380	150 New	150 $11,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84.7B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.